FdaApplication
ANDA 213823
Identifiers
- fda_app_no: ANDA213823
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | ANDA |
| approval_date | 2022-05-02 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BORTEZOMIB | BORTEZOMIB | 3.5MG/VIAL | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
1 product